Roswell Park appoints chair in gynecologic oncology
Click Here to Manage Email Alerts
Emese Zsiros, MD, PhD, has been promoted to lead the department of gynecologic oncology at Roswell Park Comprehensive Cancer Center.
Zsiros, who has been on staff at the institution since 2014, also will serve as Shashi Lele, MD, endowed chair in gynecologic oncology.
Zsiros is recognized for her expertise in immunotherapy and minimally invasive surgery.
She most recently served as director of research and associate director of fellowships within gynecologic oncology at Roswell Park.
She has led research designed to safely reduce the number of opioid doses prescribed to patients undergoing surgery. Zsiros also helped lead a study that showed the combination of pembrolizumab (Keytruda, Merck), bevacizumab (Avastin, Genentech) and a pill form of cyclophosphamide conferred long-term disease control with excellent quality of life for women with recurrent ovarian cancer.
“Dr. Zsiros’ pioneering work in devising, implementing and documenting a new approach to pain management for patients undergoing surgery has been broadly adopted by surgery programs both inside and outside oncology, with pronounced advantages for patients and the communities they live in,” Candace S. Johnson, PhD, president, CEO and M&T Bank presidential chair in leadership at Roswell Park, said in a press release. “It was also Dr. Zsiros who proposed a novel treatment combination for patients with late-stage ovarian cancer, a strategy shown to generate long-term clinical benefits for patients with this notoriously hard-to-treat cancer type.”
Read more about
Click Here to Manage Email Alerts